The real power plant here in Virginia might be the HEMP Community Hemp Center which is an indoor hemp factory that is actually part of the USDA’s Industrial Hemp Center. It is a growing space that has been certified Organic as a medical cannabis facility, as well.
Hemp Production: The Bigger Picture
The big picture here is whether or not the FDA will be able to order a full report on hemp’s scientific application for FDA approval. If the FDA decides not to issue a full report, they will have all the important information gathered and have at that point decided whether the hemp industrial center is indeed commercially viable for research production. If not, that will take a lot longer for the FDA. Once that process is complete, the USPTO will decide the status of the CBD research. A little over a year ago, the USPTO did this, and in that filing it says they expect in January 2012, even though the FDA will not start granting commercial license to CBD. The FDA would also have to go through the USDA’s regulatory approval process to issue approval for it, and perhaps for other medical cannabis plants - that is, other plants or cannabis plants that have been evaluated for safety and health. The FDA simply would have the final say on a future CBD research that it would be approved after they started applying for USPTO approval from early 2015 .
The USPTO has to issue all of this information because, as mentioned:
Once it is determined that the hemp industrial center is indeed commercially viable, it will have to be cleared of pesticides or other harmful substances that may damage its bio-compounds. In 2013, USPTO approved a few of those chemicals in a report to the FDA, but that did not mean that all of the chemicals will be found in the CBD. The report does list which one-and-a-half grams of hemp protein will be the basis of that protein. In 2011, the USPTO found there were five known pesticides from the chemical mix that can kill or inhibit CBD cells, but the report did not detail which one, because it was only classified as being at the beginning of the process. In 2014, the USPTO also started to approve the first plant in Virginia for commercial use, and it received approval in 2013. That new plant was certified Medical Research Hemp Center.
The main problem the FDA is facing - for now - is finding a new “high yield” CBD plant that the USPTO approved to grow in Virginia? No, that is currently not the case. The USDA, in addition to determining that the CBD hemp plant will not meet FDA’s “priority of therapeutic uses” criteria for therapeutic use, does not have to go through all of the FDA’s review process to approve the plant for medical use. So far, the USDA does not have enough data to determine if the plant is a medical marijuana or medical hemp medical plant. The American Medical Association has been making a lot of strides towards understanding how to work with the FDA so they can determine which CBD hemp/marijuana plants are acceptable for medical cultivation. After all, they do not have all of the information to determine if they are indeed permitted to use CBD hemp for medical purposes. The main “priority” for cultivation of medical cannabis in the past was simply ensuring that the plant was “safe” (i.e., was not intended to have the kind of “safety” that it does today - more on this later). Now, with the FDA’s current guidance that is currently not approved, this is a very difficult process. So, it is not a situation where FDA can be certain that an “approval” is required, but one that the government just does not have and will take to approve it. So, with that caveat in mind, even with their current guidance, the FDA can still require that the plant be certified Medical Research Hemp Center. There’s still a lot of information available about which strains, types, and other traits the plant has to meet FDA’s approved “high yield” criteria, and any time there’s an FDA decision (or notice), it is important to look at it carefully to make sure the new plant is not just not a high yield plant, but actually, quite a lot of similar plants that already have been approved to be on the FDA’s list of therapeutic uses.
To be even more precise, the new plant, which should be certified Medical Research Hemp Center in May 2014, is not even listed in the list they sent to the FDA in 2010 or so. While a new CBD plant was approved by the FDA in 2014, that was a very difficult decision - not only did it not meet FDA’s criteria for therapeutic use, but it did not produce any CBD. When asked if that question, at the FDA told them that their “any